NASDAQ:AERI
Aerie Pharmaceuticals, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.aeriepharma.comipo date
Oct 25, 2013
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with op...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus